Zobrazeno 1 - 10
of 21
pro vyhledávání: '"M. Catherine Driscoll"'
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0129431 (2015)
The molecular mechanisms governing γ-globin expression in a subset of fetal hemoglobin (α2γ2: HbF) expressing red blood cells (F-cells) and the mechanisms underlying the variability of response to hydroxyurea induced γ-globin expression in the tr
Externí odkaz:
https://doaj.org/article/1bf9795452a7443d9b54f760ae6f1f15
Publikováno v:
Neonatology ISBN: 9781610022248
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abc99c2500c4c84eefbf60b932cd15f9
https://doi.org/10.1542/9781610022255-28
https://doi.org/10.1542/9781610022255-28
Autor:
Nerissa Velazco, Andrew D. Racine, Farzana Pashankar, M. Catherine Driscoll, Patricia J. Giardina, Rebecca Trachtman, Suzette O. Oyeku, Craig A. Mullen, Nancy S. Green, Hillel W. Cohen
Publikováno v:
Pediatric Blood & Cancer. 60:653-658
Background Hydroxyurea (HU) is highly effective treatment for Sickle Cell Disease (SCD). While pediatric use of HU is accepted clinical practice, barriers to use may impede its potential benefit.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2eafc4fc3f4ec4c73aaf2d701665d0d5
https://doi.org/10.1002/pbc.24381
https://doi.org/10.1002/pbc.24381
Publikováno v:
Blood. 110:3526-3531
Patients with severe immune thrombocytopenic purpura (ITP) may require an acute increase in the platelet count for surgery or ongoing hemorrhage as well as long-term maintenance treatment. Certain of these patients may be refractory to steroids, intr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2714f503ed20e2985b36b2096d096736
https://doi.org/10.1182/blood-2007-01-065763
https://doi.org/10.1182/blood-2007-01-065763
Autor:
M. Catherine Driscoll
Publikováno v:
Pediatrics In Review. 28:259-268
1. M. Catherine Driscoll, MD* 1. *Director, Hematology Program, Children's Hospital at Montefiore, Bronx, NY After completing this article, readers should be able to: 1. Describe the pathogenesis of sickle cell disease. 2. Delineate the complications
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a9377ff6b01d017973cb03db2e2d449
https://doi.org/10.1542/pir.28.7.259
https://doi.org/10.1542/pir.28.7.259
Autor:
Dorothy I. Bulas, M. Catherine Driscoll, Tonya Kratovil, Barbara Speller-Brown, Robert McCarter, Caterina P. Minniti
Publikováno v:
Pediatric Blood & Cancer. 47:894-900
Hydroxyurea (HU) improves hematologic parameters and decreases adverse events in patients with sickle cell disease (SCD). HU has been proposed as an alternative to chronic transfusions for secondary stroke prevention. Transcranial doppler (TCD) is an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::972e714121d9dfd4ea9cb3f89de3acf3
https://doi.org/10.1002/pbc.20819
https://doi.org/10.1002/pbc.20819
Autor:
Charles H. Pegelow, Lori Styles, Donald Brambilla, Anne Hurlet, Brian Berman, Kantilal Patel, M. Catherine Driscoll, Virgil McKie, Beatrice Files, Nancy F. Olivieri, Richard A. Drachtman
Publikováno v:
Blood. 101:2401-2404
Cerebrovascular disease is a common cause of morbidity in sickle cell anemia (HbSS): approximately 10% of patients have a clinical stroke before 20 years of age, and another 22% have silent infarction on magnetic resonance imaging. The phenotypic var
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58769fbc0e3f9eb1292755e0a6dcd357
https://doi.org/10.1182/blood.v101.6.2401
https://doi.org/10.1182/blood.v101.6.2401
Autor:
Robert P. Hirsch, Griffin P. Rodgers, Kye Hyun Kim, M. Catherine Driscoll, Wenli Liu, Ron Prauner, Delia C. Tang
Publikováno v:
American Journal of Hematology. 68:164-169
Stroke is one of the most devastating complications of patients with sickle cell disease (SCD). Currently, there are no known molecular or genetic markers that can be used to assess the risk of stroke in this population. We have previously shown that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::154d4b8bb59264f4f1a586efe2ab7235
https://doi.org/10.1002/ajh.1173
https://doi.org/10.1002/ajh.1173
Autor:
M. Catherine Driscoll, Guy Young
Publikováno v:
American Journal of Hematology. 60:66-69
The carbohydrate-deficient glycoprotein syndromes are a group of recently described autosomal recessive, metabolic defects affecting multiple systems. The disorder is caused by inefficient posttranslational glycosylation of glycoproteins. Patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91785890fbb4301eb0cd206a8e11a98b
https://doi.org/10.1002/(sici)1096-8652(199901)60:1<66::aid-ajh11>3.0.co
https://doi.org/10.1002/(sici)1096-8652(199901)60:1<66::aid-ajh11>3.0.co
Autor:
Swapnil Rajpathak, Karen Moody, M. Catherine Driscoll, Kris Michael Mahadeo, Ruth Santizo, Benjamin H. Taragin, Suzette O. Oyeku
Publikováno v:
American journal of hematology. 86(9)
anemia. Blood 2010;115:5300–5311. 10. Thornburg CD, Calatroni A, Telen M, Kemper AR. Adherence to hydroxyurea therapy in children with sickle cell anemia. J Pediatr 2010;156:415–419. 11. Sichle Cell Disease Guidelines-Hydroxyurea Chapter. http://
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7b529efbe868d7970c4163a80d5bc6c
https://pubmed.ncbi.nlm.nih.gov/21850660
https://pubmed.ncbi.nlm.nih.gov/21850660